Psilocybin
Other names Magic Mushrooms
This nootropic has no healthy human placebo-controlled studies that meet our inclusion criteria. Negative side effects can occur if used carelessly, so make sure you’re aware of the risks of Psilocybin.
Risks
The legality and side effects of Psilocybin
You should always consider the risks of a nootropic before you use it.
Side effects
Interactions
Supplements and drugs can interact with Psilocybin to increase or decrease the positive or negative effects you experience. If you are already using any supplements or drugs, speak with your trusted medical professional before you experiment with Psilocybin. To learn more about the potential interactions between Psilocybin and other substances, use interaction-checker.
Legality
Is your country not included? Learn how to find out if Psilocybin is legal in your country.
Legality Disclaimer
The contents herein are not legal advice or a substitute for legal counsel. information is not intended to create, and receipt of it does not constitute, an attorney-client relationship. While we have done our best to be as accurate as possible in the information we convey to you about the legality of nootropics, there is a risk for inaccuracies and errors. If you’re uncertain about the legality of any of your actions, contact a legal counsel or your local authorities governing the legality of various substances you may want to use/import/travel with.
Studies
Studies conducted on the effects of Psilocybin in healthy humans
No placebo-controlled trials on healthy humans that meet our inclusion criteria have been conducted on Psilocybin.
Summary
"Analyses of pre and post study measures revealed reductions in reported levels of depression and stress; lower levels of distractibility; increased absorption; and increased neuroticism."
Summary
"PY affects core dimensions of altered states of consciousness and physiological parameters in a dose-dependent manner. Our study provided no cause for concern that PY is hazardous with respect to somatic health."
Summary
"Psilocybin was found to significantly impair subjects' ability to (1) reproduce interval durations longer than 2.5 sec, (2) to synchronize to inter-beat intervals longer than 2 sec and (3) caused subjects to be slower in their preferred tapping rate. These objective effects on timing performance were accompanied by working-memory deficits and subjective changes in conscious state, namely increased reports of 'depersonalization' and 'derealization' phenomena including disturbances in subjective 'time sense."
Summary
"These findings provide first evidence that psilocybin has distinct effects on social cognition by enhancing emotional empathy but not moral behavior."
Summary
"The results confirm that non-pharmacological variables play an important role in the effects of psilocybin."
Summary
"The results suggest that the administration of moderate doses of psilocybin to healthy, high-functioning and well-prepared subjects in the context of a carefully monitored research environment is associated with an acceptable level of risk."
Last updated Saturday, June 10, 2023